| Efficacy of berberine in patients with non-alcoholic fatty liver disease HM Yan, MF Xia, Y Wang, XX Chang, XZ Yao, SX Rao, MS Zeng, YF Tu, ... PloS one 10 (8), e0134172, 2015 | 237 | 2015 |
| Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method MF Xia, HM Yan, WY He, XM Li, CL Li, XZ Yao, RK Li, MS Zeng, X Gao Obesity 20 (2), 444-452, 2012 | 181 | 2012 |
| Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway X Zhu, H Bian, L Wang, X Sun, X Xu, H Yan, M Xia, X Chang, Y Lu, Y Li, ... Free Radical Biology and Medicine 141, 192-204, 2019 | 177 | 2019 |
| A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese MF Xia, Y Chen, HD Lin, H Ma, XM Li, Q Aleteng, Q Li, D Wang, YU Hu, ... Scientific reports 6 (1), 38214, 2016 | 158 | 2016 |
| Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21 Y Sun, M Xia, H Yan, Y Han, F Zhang, Z Hu, A Cui, F Ma, Z Liu, Q Gong, ... British journal of pharmacology 175 (2), 374-387, 2018 | 133 | 2018 |
| Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study H Yan, M Xia, X Chang, Q Xu, H Bian, M Zeng, S Rao, X Yao, Y Tu, W Jia, ... PloS one 6 (9), e24895, 2011 | 119 | 2011 |
| NAFLD and diabetes: two sides of the same coin? Rationale for gene-based personalized NAFLD treatment MF Xia, H Bian, X Gao Frontiers in pharmacology 10, 877, 2019 | 110 | 2019 |
| Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans L Wu, M Xia, Y Duan, L Zhang, H Jiang, X Hu, H Yan, Y Zhang, Y Gu, ... Cell death & disease 10 (6), 468, 2019 | 94 | 2019 |
| Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes L Liu, H Yan, MF Xia, L Zhao, M Lv, N Zhao, S Rao, X Yao, W Wu, B Pan, ... Diabetes/metabolism research and reviews 36 (5), e3292, 2020 | 86 | 2020 |
| Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study MF Xia, LY Chen, L Wu, H Ma, XM Li, Q Li, Q Aleteng, Y Hu, WY He, ... Clinical nutrition 40 (2), 571-580, 2021 | 84 | 2021 |
| Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease X Chang, Z Wang, J Zhang, H Yan, H Bian, M Xia, H Lin, J Jiang, X Gao Journal of Translational Medicine 14, 1-11, 2016 | 80 | 2016 |
| Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: The Shanghai Changfeng Study L Wu, H Lin, J Gao, X Li, M Xia, D Wang, Q Aleteng, H Ma, B Pan, X Gao PloS one 12 (9), e0184607, 2017 | 70 | 2017 |
| Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression X Zhu, H Yan, M Xia, X Chang, X Xu, L Wang, X Sun, Y Lu, H Bian, X Li, ... Lipids in health and disease 17, 1-9, 2018 | 64 | 2018 |
| The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet X Chang, H Yan, Q Xu, M Xia, H Bian, T Zhu, X Gao Lipids in health and disease 11, 1-8, 2012 | 61 | 2012 |
| Association of visceral adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: a prospective cohort study MF Xia, HD Lin, LY Chen, L Wu, H Ma, Q Li, Q Aleteng, Y Chen, YX Sun, ... Diabetes/metabolism research and reviews 34 (7), e3048, 2018 | 60 | 2018 |
| Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study X Li, M Xia, H Ma, A Hofman, Y Hu, H Yan, W He, H Lin, J Jeekel, N Zhao, ... Atherosclerosis 224 (2), 480-485, 2012 | 60 | 2012 |
| The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women MF Xia, HD Lin, HM Yan, H Bian, XX Chang, LS Zhang, WY He, X Gao Journal of translational medicine 14, 1-11, 2016 | 53 | 2016 |
| Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2 B Liu, L Xiang, J Ji, W Liu, Y Chen, M Xia, Y Liu, W Liu, P Zhu, Y Jin, ... The Journal of clinical investigation 131 (20), 2021 | 52 | 2021 |
| Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver M Xia, P Chandrasekaran, S Rong, X Fu, MA Mitsche Journal of lipid research 62, 2021 | 50 | 2021 |
| DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing Y Li, J Xu, Y Lu, H Bian, L Yang, H Wu, X Zhang, B Zhang, M Xiong, ... Cell metabolism 33 (10), 2004-2020. e9, 2021 | 48 | 2021 |
